DYAZIDE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Hydrochlorothiazide; Triamterene.
Product ID | 0007-3650_20d05ffc-42d0-4847-ba0e-b6f7ee1c7b94 |
NDC | 0007-3650 |
Product Type | Human Prescription Drug |
Proprietary Name | DYAZIDE |
Generic Name | Hydrochlorothiazide And Triamterene |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 1994-03-30 |
Marketing Category | NDA / NDA |
Application Number | NDA016042 |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
Active Ingredient Strength | 25 mg/1; mg/1 |
Pharm Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 1994-03-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA016042 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1994-03-30 |
Marketing Category | NDA |
Application Number | NDA016042 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1994-03-30 |
Marketing End Date | 2020-04-29 |
Ingredient | Strength |
---|---|
HYDROCHLOROTHIAZIDE | 25 mg/1 |
SPL SET ID: | f6eba4b6-9cd0-4c86-46a8-05a202641c89 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0007-3650 | DYAZIDE | hydrochlorothiazide and triamterene |
55154-4510 | DYAZIDE | hydrochlorothiazide and triamterene |
65084-135 | DYAZIDE | hydrochlorothiazide and triamterene |